Presentación
CLINICAL PHARMACOLOGY


farmacologiaclinica@idipaz.es

Excellent Group
Composition
Name
Position
Institution
Antonio Javier Carcas Sansuán
Jefe de Servicio

Profesor Titular. Facultad de Medicina 
Hospital Universitario La Paz
Universidad Autónoma de Madrid
Pilar Ayllón García
Técnico de laboratorio
Universidad Autónoma de Madrid
Alberto Borobia Pérez
Facultativo Especialista de Área en Farmacología Clínica
Hospital Universitario La Paz
Raquel de Madariaga Castell
Enfermera. Coordinadora de Ensayos Clínicos
FIBHULP
Lucía Díaz García
Facultativo Especialista en Farmacología Clínica
Hospital Universitario La Paz
Jesús Frías Iniesta
Catedrático Emérito. Facultad de Medicina
Universidad Autónoma de Madrid
Blanca Duque Bascuñana
Responsable de calidad
Universidad Autónoma de Madrid
Alberto García Bartolomé
Investigador Postdoctoral 
Hospital Universitario La Paz
Irene García García
Facultativo Especialista en Farmacología Clínica
Hospital Universitario La Paz
Andrea Guzmán de Antonio
Investigadora Predoctoral
FIBHULP
Cristina López Crespo
Enfermera. Coordinadora de Ensayos Clínicos
FIBHULP
Alicia Marín Candón
Medico Especialista en Farmacología Clínica
FIBHULP
José Carlos Martínez Ávila
Investigador Postdoctoral 
Hospital Universitario La Paz
Lucía Martínez de Soto
Coordinadora de Ensayos Clínicos
FIBHULP
Vega Mauleón Martínez
Enfermera. Coordinadora de Ensayos Clínicos
FIBHULP
Pablo Molina Benítez
Investigador Predoctoral 
FIBHULP
Paloma Moraga Alapont
Gestora de proyectos SCReN (Spanish Clinical Research Network)
FIBHULP
María Cristina Murano Murano
Investigador Postdoctoral
FIBHULP
Paula Prieto Correa
Monitora de Ensayos Clínicos
FIBHULP
Rocío Prieto Pérez
Gestora de proyectos SCReN (Spanish Clinical Research Network)
FIBHULP
Laura Vitón Vara
Enfermera. Coordinadora de Ensayos Clínicos
FIBHULP
Hoi Yan Tong
Responsable de Farmacovigilancia
Hospital Universitario La Paz
Strategic Objective
Clinical pharmacology, as a scientific and professional discipline, has the objective of achieving an effective, efficacious and efficient use of drugs, at both the individual and group level. This means that Clinical Pharmacology is a cross-sectional discipline that must establish collaborations with numerous other disciplines and health professionals.
In this context and in the field of clinical research, the interests of our group are focused on two fundamental aspects:
1. Customisation of drug treatments: research and development of techniques and methods that individualise the use of drugs, improve their efficacy and reduce their risks.
2. The improvement of treatment by obtaining high quality evidence on the efficacy of clinical trials, strategies of identification, evaluation and prevention of adverse reactions to medication (pharmacovigilance programmes) and evaluation of the suitability of their use and effectiveness (studies on the use of medication).
Research Lines
• Therapeutic drug monitoring (TDM) - Development of individualised therapeutic drug monitoring programmes and pharmacogenetics.
• Getting quality evidences for the stablishment of drug efficacy, safety and adecuate use of medicines in humans.
Portfolio Services/Prices
Prices (2022/04/20 Version)